BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27135371)

  • 1. (E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors.
    Desideri N; Proietti Monaco L; Fioravanti R; Biava M; Yáñez M; Alcaro S; Ortuso F
    Eur J Med Chem; 2016 Jul; 117():292-300. PubMed ID: 27135371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties.
    Desideri N; Bolasco A; Fioravanti R; Monaco LP; Orallo F; Yáñez M; Ortuso F; Alcaro S
    J Med Chem; 2011 Apr; 54(7):2155-64. PubMed ID: 21405131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
    J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.
    Chimenti P; Petzer A; Carradori S; D'Ascenzio M; Silvestri R; Alcaro S; Ortuso F; Petzer JP; Secci D
    Eur J Med Chem; 2013 Aug; 66():221-7. PubMed ID: 23807114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.
    Chimenti F; Bolasco A; Secci D; Chimenti P; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
    Bioorg Med Chem; 2010 Aug; 18(15):5715-23. PubMed ID: 20615716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors.
    Chen R; Xiao J; Ni Y; Xu HF; Zheng M; Tong X; Zhang TT; Liao C; Tang WJ
    Bioorg Med Chem; 2016 Apr; 24(8):1741-8. PubMed ID: 26964672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
    Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
    J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
    Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
    Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.
    Ruan BF; Cheng HJ; Ren J; Li HL; Guo LL; Zhang XX; Liao C
    Eur J Med Chem; 2015 Oct; 103():185-90. PubMed ID: 26352677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
    Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
    Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives.
    Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H
    Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
    Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
    Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,5-Diphenylpenta-2,4-dien-1-ones as potent and selective monoamine oxidase-B inhibitors.
    Desideri N; Fioravanti R; Proietti Monaco L; Biava M; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2013 Jan; 59():91-100. PubMed ID: 23207410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
    Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease.
    Liu L; Chen Y; Zeng RF; Liu Y; Xie SS; Lan JS; Ding Y; Yang YT; Yang J; Zhang T
    Bioorg Chem; 2021 Apr; 109():104685. PubMed ID: 33640631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
    Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
    Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation.
    Wang D; Hong RY; Guo M; Liu Y; Chen N; Li X; Kong DX
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31694262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
    Zarmouh NO; Eyunni SK; Soliman KF
    BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
    Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
    ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.